{
  "Q0": "Whole exome sequencing (WES) to investigate potential underlying genetic causes of neurodevelopmental delay and seizures. Gene content: all protein-coding regions of the genome.",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4_followup": [
    "ACMG"
  ],
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Not specified",
  "Q10": "No",
  "Q10_followup": [
    "Diagnostic"
  ],
  "Q11": "No",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "Submit the claim with documentation of the patient's clinical presentation (neurodevelopmental delay, seizures, negative prior CMA, family history), the specialist's order for WES, and evidence that prior testing (CMA) was negative. Include a letter of medical necessity referencing ACMG guidelines and the policy's criteria for genetic testing in neurodevelopmental disorders. Attach all relevant clinical notes and genetic counseling documentation if available."
}